Centric Health Corp. (TSE:CRX – Free Report) – Equities research analysts at Ventum Cap Mkts decreased their FY2024 earnings per share (EPS) estimates for Centric Health in a research report issued to clients and investors on Monday, November 11th. Ventum Cap Mkts analyst S. Quenneville now forecasts that the company will post earnings per share of ($0.05) for the year, down from their previous forecast of ($0.04). Ventum Cap Mkts currently has a “Strong-Buy” rating on the stock.
Separately, Stifel Canada lowered Centric Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 12th.
Centric Health Stock Performance
See Also
- Five stocks we like better than Centric Health
- How to Effectively Use the MarketBeat Ratings Screener
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Investing In Preferred Stock vs. Common Stock
- Top-Performing Non-Leveraged ETFs This Year
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
